CEL-SCI (CVM) Director Watson Receives 110,000-Share Award

What Happened Watson Robert Eugene, a director of CEL-SCI Corp. (CVM), received a grant of derivative securities on August 14, 2026. The filing reports a grant of 110,000 stock options (derivative) with an exercise price of $0.01 per share, for a total reported value of $1,100. This is an award/compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-14; Form 4 filed: 2026-08-17.
• Grant: 110,000 stock options at $0.01 per share; total reported value $1,100.
• Vesting: Options vest in three equal annual installments beginning one year after the grant date (footnote F1).
• Shares owned after transaction: not reported in the provided data.
• Filing timeliness: No late filing is indicated in the supplied information.

Context This was a compensation-style option grant, which is common for directors and does not represent an open-market buy or sale. The vesting schedule means the options will become exercisable over the next three years (starting one year after the grant), so any future exercises or sales would be reported separately. Such awards are standard corporate compensation and should be interpreted differently from direct purchases or sales by insiders.